Deborah Friedman
Neurology · Dallas, TXNPI 1023036340
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 19.6%. Reporting peaked in 2023 at $75,532 and has fallen 57.6% since, to $32,019 in 2025. Among neurology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 332 payments — averaging $854.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$56K
- Pfizer$51K
- Axsome Therapeutics, Inc.$31K
- Lilly USA, LLC$29K
- Teva Pharmaceuticals USA, Inc.$26K
- Eli Lilly$23K
- plus $69K from 15 others
Across 68 payments — averaging $5130.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$195K
- Eli Lilly$135K
- Merck$18K
What the payments were for
- Consulting fees$93,89433%
- Speaking & faculty fees$143,95251%
- Travel & lodging$33,86012%
- Food & beverage$11,9084%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 81 | $55,630 |
| Pfizer(2 entities) | 37 | $50,629 |
| Axsome Therapeutics, Inc. | 16 | $30,579 |
| Lilly USA, LLC | 56 | $28,510 |
| Teva Pharmaceuticals USA, Inc. | 39 | $26,385 |
| Eli Lilly | 8 | $23,112 |
| Lundbeck LLC | 28 | $17,672 |
| Biodelivery Sciences International, Inc. | 12 | $8,957 |
| Pfizer Chile S.A. | 1 | $8,740 |
| Supernus Pharmaceuticals, Inc. | 14 | $8,144 |
| Impel Pharmaceuticals Inc. | 10 | $8,025 |
| Pfizer S.A. | 1 | $7,240 |
| Scilex Pharmaceuticals Inc. | 5 | $5,451 |
| Amneal Pharmaceuticals LLC | 3 | $2,854 |
| Amgen | 11 | $564 |
| Tonix Medicines, Inc. | 2 | $540 |
| Siemens Medical Solutions USA, Inc. | 3 | $331 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $88 |
| Promius Pharma LLC | 2 | $86 |
| Upsher-smith Laboratories LLC | 1 | $57 |
| SK Life Science, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$48,317
- UBRELVY$43,615
- QULIPTA$34,069
- AJOVY$25,443
- Symbravo$16,414
- ELYXYB - CELECOXIB$14,126
- ZAVZPRET$8,766
- VYEPTI$8,211
- TROKENDI XR$8,011
- Trudhesa$7,757
- EMGALITY$803
- ZEMBRACE SYMTOUCH$500
- BOTOX$300
- REYVOW$236
- AIMOVIG$233
- ARTIS icono biplane$171
How this compares
$283,614 in reported general payments places this provider in the 95th percentile of 1,246 neurology providers in Texas.
Other neurology in Dallas
- Nirav PavasiaDallas$1.4M
- Benjamin GreenbergDallas$773K
- Waleed El-FekyDallas$587K
- Adnan SubeiDallas$477K
- Steven HerzogDallas$461K
- Priyanka ChaudhryDallas$329K
- Mark AlbertsDallas$212K
- Aanchal TanejaDallas$169K
- Salman BhaiDallas$133K
- Ann BassSan Antonio$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.